Triazole-coumarins

ABSTRACT

Coumarine compounds of the formula   IN WHICH A denotes a carbocyclic aryl radical or a radical of the formula   IN WHICH X represents -CH- or N and Y represents   WHEREIN THE RADICALS R1, R2, Z1, Z2, B, R&#39;&#39;, R&#39;&#39;&#39;&#39;, An and n have the same meaning as in the description, WITH THE PROVISO THAT AT LEAST ONE OF THE RADICALS A and B represents a heterocyclic radical   AS WELL AS THEIR PREPARATION AND THEIR USE AS OPTICAL BRIGHTENERS.

United States Patent [191 Boehmke et al.

[4 Dec. 9, 1975 TRlAZOLE-COUMARINS [75] Inventors: Giinther Boehmke; Hans Theidel, both of Leverkusen, Germany [73] Assignee: Bayer Aktiengesellschaft,

Leverkusen-Bayerwerk, Germany [22] Filed: Oct. 15, 1971 [21] Appl. No.: 189,773

[44] Published under the Trial Voluntary Protest Program on January 28, 1975 as document no. B 189,773.

[30] Foreign Application Priority Data Oct. 15, 1970 Germany 2050726 [51] Int. Cl. C07D 249/06;-C07D 249/08 [58] Field of Search .260/308 R, 308 A [56] References Cited UNITED STATES PATENTS 3,663,560 5/1972 Schellhammen 260/308 R Primary Examiner-John M. Ford Attorney, Agent, or FirmP1umley & Tyner [57] ABSTRACT Coumarine compounds of the formula in which A denotes a carbocyclic aryl radical or a radical of the formula in which X represents CH or N and Y represents wherein the radicals R R Z 2,, B, R, R, An'and n have the same meaning as in the description,

with the proviso that at least one of the radicals A and B represents a heterocyclic radical as well as their preparation and their use as optical brighteners.

5 Claims, N0 Drawings TRIAZOLE-COUMARINS The subject of the present invention are coumarine compounds of the formula 5 A An (l) in which A denotes a carbocyclic aryl radical or a radical of the formula Zr\ -X Y in which X represents Cl-lor N and Y represents wherein R and R denote hydrogen, alkyl or aryl radicals and Z and Z represent the remaining members of an aromatic S-membered or 6-membered heterocyclic structure,

B represents hydrogen, halogen, an identical or different radical A, or an alkyl, acylamino, etherified hydroxyl, nitrile, optionally modified carboxyl or sulphonamide group,

R denotes hydrogen or alkyl,

R" denotes a non-ionic substituent and An 9 denotes a colourless anion, and

n represents a number from 0 to 2,

with the proviso that at least one of the radicals A and B represents a heterocyclic radical wherein R and R preferably represent lower alkyl radicals with l 4 C atoms, which are optionally substituted, for example by halogen, nitrile, alkoxy or phenoxy groups, or phenyl radicals which are optionally substituted, for example by fluorine, chlorine, bromine, C C -alkyl or C -C alkoxy.

The alkyl radicals B and R are also preferably C -C alkyl radicals.

Suitable acylamino groups A are to be understood as alkylcarbonylamino, alkoxycarbonylamino, phenylcarbonylamino, alkylsulphonylamino, phenylsulphonylamino, alkylaminocarbonylamino and phenylaminocarbonylamino groups, with the alkyl and alkoxy radicals preferably possessing 1 4 C atoms and the phenyl radicals being able to carry further nonionic substituents.

By etherified hydroxyl groups A there are especially to be understood C C -alkoxy, optionally substituted phenoxy and benzyloxy radicals.

Possible modified carboxyl groups A are carboxylic acid ester and carboxylic acid amide groups.

Within the scope of the present invention, non-ionic substituents are to be understood as substituents which are customary in the chemistry of brighteners, such as halogen atoms or alkyl, aryl, alkoxy, aryloxy, nitrile,

carboxyl, carboxylic acid ester, carboxylic acid amide, sulphonamide, alkylsulphonyl and arylsulphonyl groups.

By the anion An there are to be understood both organic and inorganic ions, for example halogen, such as chloride, bromide or iodide, or hydroxide, carbonate, bicarbonate, alkylsulphate, sulphate, disulphate, perchlorate, phosphate, benzenesulphonate or naphthalenesulphonate, 4-chlorobenzenesulphonate, oxalate, acetate, maleinate, propionate, methanesulphonate, chloroacetate, lactate, tartrate, glycerate, citrate or benzoate ions or complex anions, such as, for example, anions of zinc chloride double salts. At the same time, the formate ion and above all the acetate ion are to be regarded as particularly suitable.

Preferred compounds within the scope of the formula are those of the formula An has the abovementioned meaning,

A represents wherein Q and Q can represent hydrogen, fluorine, chlorine, bromine, C C -alky1, C C -alkoxy and phenyl, or A represents a heterocyclic radical R and R denote hydrogen or a C -C -alkyl or phenyl radical, and

Q Q and Q denote hydrogen, chlorine, a C -C4- alkyl, phenyl, nitrile, carboxyl, carbonamide or carboxylic acid ester radical, and

B represents C,C -alkoxy or an identical or different radical A, with the proviso that at least one radical A and B represents one of the abovementioned heterocyclic radicals. The new coumarine compounds of the formula I are obtained if compounds of the formula (Rm- -Dt \ojzo (III) in which D represents a carbocyclic aryl radicalhaving the abovementioned meaning, or the radical of an aromatic S-membered or 6-membered heterocyclic structure of the formula wherein X, Z and Z have the abovementioned meaning and X represents a tertiary ring nitrogen atom, D represents hydrogen, an identical or different radical D or halogen or an alkyl, an acylamino, an etherified hydroxyl, a nitrile, an optionally modified carboxyl or a sulphonamide group and R, R and n have the abovementioned-meaning, are

5 reacted, preferably in the presence of acids, that is to say quaternised, with compounds of the formula 21 11:: ,10 H II in which R and'R have the abovementioned meaning.

Possible starting materials for this quaternisation are preferably those coumarine compounds of the general formula Ill which are described in the following Patent Specifications:

(3-phenyl-7-(1,2,3-

(3-phenyl-7-(1,2,4-

US. Patent Specification 3,251,851 triazolyl-2)-coumarines) French Patent Specification 1,551,662 triazolyl-l )-coumarines) US. Patent Specification 3,123,617 coumarines British Patent Specification 867,592 British Patent Specification 914,719

(3-phenyl-7-pyrazolyl-l (3-C-hetaryl-coumarines) (3-(benzoxazolyl-2 coumarines) US. Patent Specifications 3,156,697 and 3,201,406 (3-pyridylcoumarines) US. Patent Specifications 3,014,041 and 3,458,880 (3-C- hetarylcoumarines) (3-N-hetarylcoumarines) (3-(1,2,4-triazolyl-1)- (3-chloropyrazolyl-7- Suitable quaternising agents of the formula IV are those described in Houben-Weyl, Methoden der Org. Chem. (Methods of Organic Chemistry), volume VI/3, page 367 and thereafter. As examples, there may be mentioned: ethylene oxide, 1,2-propylene oxide, 1,2- butylene oxide, glycid, styrene oxide, phenyl-glycidylether and epichlorohydrin.

The reaction, according to the invention, of III with IV preferably takes place inlower fatty acids, such as formic acid, acetic acid and propionic acid, as the reaction media. 1

In those cases in which the ring nitrogen atom to be quaternised has a relatively high, basicity, as is, for example, the case with pyridine, the process can also be carried out in an aqueous or aqueous-organic medium.

Suitable organic solvents are: methanol, ethanol, .isopropanol, butanol, acetone, methyl ethyl ketone, glycol, propylene, glycol, methyl-, ethyland butylglycol-ether, formic acid methyl ester, glycerol monoacetate, formamide, dimethylformamide, dimethylsulphoxide and methylpyrrolidone.

When carrying out the process in aqueous and aqueous-organic media it is advisable to maintain the pH value of the reaction mixture, which can rise as far as 13 through formation of the quaternary base, at 79 by continuous addition of acid.

Suitable acids are, for example, mineral acids, arylsulphonic acids and lower monobasic and dibasic aliphatic carboxylic acids.

The following acids may be mentioned as examples: hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, benzenesulphonic and toluenesulphonic acid, benzenecarboxylic and toluenecarboxylic acid, p-hydroxybenzoic and o-hy'droxybenzoic acid, formic acid, acetic acid, propionic acid, lactic acid, malic acid, tartaric acid, citric acid and others.

The reaction temperatures can be varied over a substantial range.

In general the process is carried out at 0 to 80C, preferably to 50C.

The molar ratios of the reactants can also be varied widely.

In carrying out the reaction according to the invention in an aqueous or aqueous-organic medium, the reactants III and IV are in general employed in the ratio of 1:1, but an excess of IV normally does not influence the desired course of the reaction.

When working in pure lower fatty acids it is, on the other hand, advisable to use a 2-fold to 5-fold excess of IV.

The new coumarine compounds of the formula I barely retain any tendency to crystallise and are almost infinitely soluble in water as well as in polar organic solvents. They are therefore much more suitable than the nearest comparable quaternary coumarine bases, known from the abovementioned Patent Specifications, for the manufacture of concentrated, stable liquid compositions, such as are required, say, for automatically controlled processes for the treatment of fibres and fabrics.

In contrast to the conventional methods for the manufacture of concentrated liquid compositions of optical brighteners, which are characterised by the use of special solvents for the types of brighteners already known as powder products, the process according to the invention for the manufacture of liquid compositions is characterised by lesser technical effort and hence by a considerable saving in cost.

Furthermore, the use of solvents, solubilising agents and other auxiliaries frequently presents greater difficulties in the case of brighteners than, for example, in the case of dyestuffs, since in the case of brighteners it can result in very severe colour shade distortions (for example development of a green tone), reduction in fluorescence and even, for example if molecular adducts are formed, quenching of the fluorescence.

Finally, in the present case another conventional process for the manufacture of concentrated brightener solutions, which is characterised by the use of special counter-ions for example acetate ions instead of the otherwise customary halide ions and sulphate ions is completely unsuitable, since this ion exchange takes place via the bases liberated by addition of alkali, in the course of which the sensitive lactone ring of the coumarines would be splitopen.

EXAMPLE I CHs- N H I I 1 N N N 0 (according to French Pat. Specification No.

1,567,497) are dissolved in g of formic acidand 20 g of benzene at 50C. Ethylene oxide is then passed in for about 3 4 hours. 3 5 timesthe theoretical absorption of ethylene oxide is necessary until a sample freed of benzene gives a clear solution in water. Thereafter the benzene, and the greater part of the formic acid, are distilled from the entire batch in vacuo. The residue consists of the brightener of the structure given below and of formic acid glycol ester, and these can be taken up in water to give a 20 30% strength solution:

10 g of the 3,7-di-triazolyl-coumarine derivative according to German Published Application No. (DOS) N CH: N

i iii 02115 N I O '7 are dissolved in 15 g of formic acid and 50 g of'chlorobenzene by warming. Ethylene oxide is then slowly passedin at 20C. The solution, which initially. turns cloudy, becomes clear after 6 8 hours. Small amounts of dissolved ethylene oxide, excess formic acid and the chlorobenzene are distilled off in .vacuo;.The 'chloro benzene is totally removed bymeansof a vacuum steam distillation. A l0-40% strength solution, depend Continued 7-position 3-position Anion CH -=1II ,do.. HCOO- N CH3 \N/ do Hooo- 7 N- .do HCOO" CH; N

Same as above i Same as above.

- CII3 D Do.

- -OCH;

EXAMPLE 3 wherein R and R independently of each other, are hydro- 40 of the coumarine derivative of th f rm 1 g e O u a (ac gen, C C -alky1, or phenyl;

cording to German Published Application No. (DOS) gen, chloro, C C -alkyl, phenyl, cyano, carboxyl, I or carbonamido; H3O N N I l B is C C -alkoxy,

i l o H30 N/ \O/ N /N N are dissolved in 80 g of acetic acid and 80 g of acetic H3O HC HC acid methyl ester at 40 -C. 18 g of phenyl-glycidyl- 40 1/ i ether (3-phenoxy-propylene oxide) are added dropwise over the course of 3 4 hours and the mixture is there'- after stirred for a further 3 hours. The acetic acid methyl ester is then distilled off. The acetic acid solution, which is of approx. 45% strength, can be em- 5 ployed for brightening polyacrylonitrile material, or N N alternatively the acetic acid can be largely removed in N vacuo and the residue adjusted with water to the de- H3C/ sired concentration, for example 30% strength. H or H C and The brightener has the following structure: 5 a

We claim: An is chloride, bromide, iodide, hydroxide, carbon- 1. Coumarine compound of the formula: ate, bicarbonate, alkylsulphate, sulphate, disulphate, perchlorate, phosphate, benzenesulphonate, naphthalenesulphonate, 4-chlorobenzenesulphonate, oxalate, acetate, maleinate, propionate, me- N ""QS (+5 thanesulphonate, chloroacetate, lactate, tartrate, glycerate, citrate, benzoate, formate or the anion N-CH-CHOH An(-) of zinc chloride double salts. O J; V R2 2. The compound of claim 1 wherein An is formate. \O Q 3. The compound of claim 1 wherein Anfiis acetate.

Q and Q independently of each other, are hydro- 9 10 4. The coumarine compound of claim 1 of the for- N Q N mula T N- N--' H \N/ CH: \N/

r N+CHGH-OH 5 B 5. The coumarine compound of claim 1 of the for- 0 mula wherein B is 0 CH3 N CH N l N N+OHrCH2OH HCOO a I CH. CH, CHa= T' 0 \O CH N CH 3 

1. COUMARINE COMPOUND OF THE FORMULA:
 2. The compound of claim 1 wherein An is formate.
 3. The compound of claim 1 wherein An is acetate.
 4. The coumarine compound of claim 1 of the formula
 5. The coumarine compound of claim 1 of the formula 